Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
great day for us
can be huge it
what is your idea and target?
thank uuuuuuuuuuuuu
great job amico
go sunshinestate !!!!!!!!!!!!!
HEY AMICO
GOOD PICK WITH SLON
I WANTED BUY ON MONDAY BUT I BOUGHT CYRX
I HOPE U MAKE GOOD MONEY $$$$
ARE U STILL IN WITH ETIM?
have a nice day
go sunshinestate
CYRX.PK on fire
check the chart
next NNRF.PK
BUY NOW OR NEVER
prestateci di natale per stasera
come va la vita con le tue azioni?
LAST CALL FOR CYRX
great post
thank you my friend
we are next NNRF
GOGOOGOGOG BABY !!!!!!!!
GO CYRXXXXXXXXXXXXXXXXXX
vedo che stai guadagnando bene
hai delle azioni che hanno bassi volumi, low float
NWBT mi sembra interessante
ciao amico
l udinese è una squadra simpatica
che azioni hai?
NNRF sta salendo alla grande
ho solo seguito i consigli sulla loro board
le notizie sono ottime
se CYRX segue il trend di NNRF sono in paradiso hahaa
if u missed NNRF.PK
buy CYRX.PK
CYRX.pk
Next NNRF.pk
hahahhaa drink some italian red wine too
The company name is Cryoport, Inc, and they are in Southern California and pioneered patented technologies in cryogenic frozen packaging at -150º C, or lower, for transporting biological materials, including a reusable shipper currently in full production. (shown in yellow below)
In the medical field in general a vast number of materials have to be shipped at these very low temperatures. Many medicines such as in the area of live cell therapeutics for use in some cancer vaccines are an example of the need to ship at low temperatures. You may download http://www.firstcapitalinvestors.com/factsheets/CYRX.pdf an 8-page information sheet about the company and its products and services as well as the huge market potential they have.
Dry ice is used by others to ship temperature sensitive materials but it has many drawbacks as it does not last long and for any delays it would have to be re-iced so this does not make it very cost effective.
CryoPort's mission is providing cost effective, cryogenic packaging system for biological materials requiring, or benefiting from, a cryogenic temperature (colder than negative 150 degrees celsius) environment over an extended time period, which will significantly replace the currently used dry ice equipment as frozen shipping containers.
The market opportunity is huge as shown in the company literature. There are currently a minimum of 20 million frozen shipments made per year within CryoPort's target market's.
They outline the market size now in these areas as:
*
Biopharmaceutical Clinical Trials $1.80 Billion
*
Biopharmaceutical Distribution $1.18 Billion
*
Biotechnology Research $0.05 Billion
*
Miscellaneous Biologicals $0.30 Billion
*
Total Global Market $3.34 Billion
There are other uses of this technology also for categories that need to be shipped at low temperatures. Think of all the perishable products you can that are now being shipped frozen and you can begin to see the potential.
In March CryoPort entered into a business alliance agreement with Commodity Sourcing Group CSG. CSG is in the supply chain management area and helps in the supply and transportation arraignment for hospitals and others. The full press release is here:
Hey amico
did u already eat some spaghetti?
The company name is Cryoport, Inc, and they are in Southern California and pioneered patented technologies in cryogenic frozen packaging at -150º C, or lower, for transporting biological materials, including a reusable shipper currently in full production. (shown in yellow below)
In the medical field in general a vast number of materials have to be shipped at these very low temperatures. Many medicines such as in the area of live cell therapeutics for use in some cancer vaccines are an example of the need to ship at low temperatures. You may download http://www.firstcapitalinvestors.com/factsheets/CYRX.pdf an 8-page information sheet about the company and its products and services as well as the huge market potential they have.
Dry ice is used by others to ship temperature sensitive materials but it has many drawbacks as it does not last long and for any delays it would have to be re-iced so this does not make it very cost effective.
CryoPort's mission is providing cost effective, cryogenic packaging system for biological materials requiring, or benefiting from, a cryogenic temperature (colder than negative 150 degrees celsius) environment over an extended time period, which will significantly replace the currently used dry ice equipment as frozen shipping containers.
The market opportunity is huge as shown in the company literature. There are currently a minimum of 20 million frozen shipments made per year within CryoPort's target market's.
They outline the market size now in these areas as:
*
Biopharmaceutical Clinical Trials $1.80 Billion
*
Biopharmaceutical Distribution $1.18 Billion
*
Biotechnology Research $0.05 Billion
*
Miscellaneous Biologicals $0.30 Billion
*
Total Global Market $3.34 Billion
There are other uses of this technology also for categories that need to be shipped at low temperatures. Think of all the perishable products you can that are now being shipped frozen and you can begin to see the potential.
In March CryoPort entered into a business alliance agreement with Commodity Sourcing Group CSG. CSG is in the supply chain management area and helps in the supply and transportation arraignment for hospitals and others. The full press release is here:
CYRX.PK
CYRX
CryoPort Reports Successful Pilot Shipments for Multiple Pharmaceutical Companies
Apr 23, 2007 7:05:00 AM
BREA, CA -- (MARKET WIRE) -- 04/23/07 -- CryoPort, Inc. (PINKSHEETS: CYRX) announced today that it has successfully completed pilot shipments of the CryoPort Express� One Way Shipper System involving medicines and biomaterials with selected pharmaceutical manufacturers.
The shipments included such destinations as Thailand and India. In addition, research biomaterials are currently shipping to South Africa. CryoPort's CEO, Mr. Peter Berry, commented, "These successful pilot shipments are particularly significant as they confirm the application of our one-way technology in shipping to locations that have historically provided significant challenges for cold chain shipments within global clinical trials. Due to the sensitivity of R&D activities within the pharmaceutical sectors, we are not able to discuss the names of our pilot partners at this time, although I am hopeful that as their programs mature we will be able to share this information with our investors."
Mr. Berry concluded, "As our pilot program partners continue to increase their usage of the CryoPort Express� platform, we are responding by taking the initial steps to establish a foundation for ramping up our manufacturing to a larger scale in an effort to meet the anticipated demand for our products."
Additional information on CryoPort, including a downloadable Investor Fact Sheet, can be found at www.firstcapitalinvestors.com/cyrx.html
About CryoPort, Inc.
CryoPort (www.cryoport.com) develops leading edge, proprietary, technology driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical sectors. The products are essential components of the infrastructure required for the testing, research and end user delivery components that make up the foundation of the biopharmaceutical and biotechnology industries.
"SAFE HARBOR"
This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Investor Relations:
First Capital Investors, Inc.
www.firstcapitalinvestors.com
321-221-2910
Email Contact
CryoPort Reports Successful Pilot Shipments for Multiple Pharmaceutical Companies
Apr 23, 2007 7:05:00 AM
BREA, CA -- (MARKET WIRE) -- 04/23/07 -- CryoPort, Inc. (PINKSHEETS: CYRX) announced today that it has successfully completed pilot shipments of the CryoPort Express� One Way Shipper System involving medicines and biomaterials with selected pharmaceutical manufacturers.
The shipments included such destinations as Thailand and India. In addition, research biomaterials are currently shipping to South Africa. CryoPort's CEO, Mr. Peter Berry, commented, "These successful pilot shipments are particularly significant as they confirm the application of our one-way technology in shipping to locations that have historically provided significant challenges for cold chain shipments within global clinical trials. Due to the sensitivity of R&D activities within the pharmaceutical sectors, we are not able to discuss the names of our pilot partners at this time, although I am hopeful that as their programs mature we will be able to share this information with our investors."
Mr. Berry concluded, "As our pilot program partners continue to increase their usage of the CryoPort Express� platform, we are responding by taking the initial steps to establish a foundation for ramping up our manufacturing to a larger scale in an effort to meet the anticipated demand for our products."
Additional information on CryoPort, including a downloadable Investor Fact Sheet, can be found at www.firstcapitalinvestors.com/cyrx.html
About CryoPort, Inc.
CryoPort (www.cryoport.com) develops leading edge, proprietary, technology driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical sectors. The products are essential components of the infrastructure required for the testing, research and end user delivery components that make up the foundation of the biopharmaceutical and biotechnology industries.
"SAFE HARBOR"
This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Investor Relations:
First Capital Investors, Inc.
www.firstcapitalinvestors.com
321-221-2910
Email Contact
great post
lets go to 2 $$$
wake up board ???????????
interview still on or its over?
thank u
what does means into on-line gamling ?
thank u
tell your dad
Forza Milan !!!!!!!!!!!!!!
i like read your post
didnt buy anything yet bc im scare
which one u suggest ?
im italian
thank u
who bought 4 milions shares???
GO MILAN !!!!!!!!!!!!!!!!
GO KAKA !!!!!!!!!!!
great im in too
ok and you?
im still with ETIM
Today is the big day
hahhaa funny
yes MAMMA MIA !!!!!!!!!!!!!!!!
thank you my friend
u are great
hahaa
pizza capricciosa hahhaa italian 100%
thank u
can i ask what do u think of CLYW?
FROM 2 CENT TO 52 CENT in less than 1 month
thank u
hey amico
what do u think of the news?
thank u
u welcome my friend
have a nice weekend
hey amico
bought more HPNN at 0.033
are u still in?
thank u
ok im great too
any news about BHUB?
thank u